Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Soratib 200 mg (containing Sorafenib) is an oral tyrosine kinase inhibitor (TKI) used to treat advanced kidney (renal cell carcinoma), liver (hepatocellular carcinoma), and thyroid cancers. It works by inhibiting multiple receptors to block angiogenesis (blood vessel formation) and tumor cell proliferation.
| Strength | 200mg |
| Pack Size | 120 Tablets |
| Dosage Form | Tablet (Film-coated) |
| Storage | Store below 30°C |
| Uses | Liver cancer, Kidney cancer, and Thyroid cancer. |
| Main Ingredients | Sorafenib |